SNSE icon

Sensei Biotherapeutics
SNSE

10 hedge funds and large institutions have $515K invested in Sensei Biotherapeutics in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$10.6K
2
+$2.84K
3
+$68

Top Sellers

1
-$11.1K
2
-$8.25K
3
-$3.14K
4
SS
SBI Securities
Japan
-$1.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
1
Ikarian Capital
Texas
$228K
CCM
2
Catalio Capital Management
New York
$157K
Renaissance Technologies
3
Renaissance Technologies
New York
$123K
Bank of America
4
Bank of America
North Carolina
$3.27K
Citigroup
5
Citigroup
New York
$3.14K
JP Morgan Chase
6
JP Morgan Chase
New York
$341
Morgan Stanley
7
Morgan Stanley
New York
$107
BNP Paribas Financial Markets
8
BNP Paribas Financial Markets
France
$96
BP
9
BNP Paribas
France
$59
SS
10
SBI Securities
Japan
$43
UBS Group
11
UBS Group
Switzerland
–